Copyright Reports & Markets. All rights reserved.

Global LFA-based Cardiac Marker Market Size, Status and Forecast 2020-2026

Request for Sample of this report
Buy now

1 Report Overview

  • 1.1 Study Scope
  • 1.2 Key Market Segments
  • 1.3 Players Covered: Ranking by LFA-based Cardiac Marker Revenue
  • 1.4 Market Analysis by Type
    • 1.4.1 Global LFA-based Cardiac Marker Market Size Growth Rate by Type: 2020 VS 2026
    • 1.4.2 Troponin
    • 1.4.3 CK-MB
    • 1.4.4 Myoglobin
    • 1.4.5 Others
  • 1.5 Market by Application
    • 1.5.1 Global LFA-based Cardiac Marker Market Share by Application: 2020 VS 2026
    • 1.5.2 Laboratory Testing
    • 1.5.3 Point-of-care Testing
  • 1.6 Study Objectives
  • 1.7 Years Considered

2 Global Growth Trends by Regions

  • 2.1 LFA-based Cardiac Marker Market Perspective (2015-2026)
  • 2.2 LFA-based Cardiac Marker Growth Trends by Regions
    • 2.2.1 LFA-based Cardiac Marker Market Size by Regions: 2015 VS 2020 VS 2026
    • 2.2.2 LFA-based Cardiac Marker Historic Market Share by Regions (2015-2020)
    • 2.2.3 LFA-based Cardiac Marker Forecasted Market Size by Regions (2021-2026)
  • 2.3 Industry Trends and Growth Strategy
    • 2.3.1 Market Top Trends
    • 2.3.2 Market Drivers
    • 2.3.3 Market Challenges
    • 2.3.4 Porter’s Five Forces Analysis
    • 2.3.5 LFA-based Cardiac Marker Market Growth Strategy
    • 2.3.6 Primary Interviews with Key LFA-based Cardiac Marker Players (Opinion Leaders)

3 Competition Landscape by Key Players

  • 3.1 Global Top LFA-based Cardiac Marker Players by Market Size
    • 3.1.1 Global Top LFA-based Cardiac Marker Players by Revenue (2015-2020)
    • 3.1.2 Global LFA-based Cardiac Marker Revenue Market Share by Players (2015-2020)
    • 3.1.3 Global LFA-based Cardiac Marker Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
  • 3.2 Global LFA-based Cardiac Marker Market Concentration Ratio
    • 3.2.1 Global LFA-based Cardiac Marker Market Concentration Ratio (CR5 and HHI)
    • 3.2.2 Global Top 10 and Top 5 Companies by LFA-based Cardiac Marker Revenue in 2019
  • 3.3 LFA-based Cardiac Marker Key Players Head office and Area Served
  • 3.4 Key Players LFA-based Cardiac Marker Product Solution and Service
  • 3.5 Date of Enter into LFA-based Cardiac Marker Market
  • 3.6 Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type (2015-2026)

  • 4.1 Global LFA-based Cardiac Marker Historic Market Size by Type (2015-2020)
  • 4.2 Global LFA-based Cardiac Marker Forecasted Market Size by Type (2021-2026)

5 LFA-based Cardiac Marker Breakdown Data by Application (2015-2026)

  • 5.1 Global LFA-based Cardiac Marker Market Size by Application (2015-2020)
  • 5.2 Global LFA-based Cardiac Marker Forecasted Market Size by Application (2021-2026)

6 North America

  • 6.1 North America LFA-based Cardiac Marker Market Size (2015-2020)
  • 6.2 LFA-based Cardiac Marker Key Players in North America (2019-2020)
  • 6.3 North America LFA-based Cardiac Marker Market Size by Type (2015-2020)
  • 6.4 North America LFA-based Cardiac Marker Market Size by Application (2015-2020)

7 Europe

  • 7.1 Europe LFA-based Cardiac Marker Market Size (2015-2020)
  • 7.2 LFA-based Cardiac Marker Key Players in Europe (2019-2020)
  • 7.3 Europe LFA-based Cardiac Marker Market Size by Type (2015-2020)
  • 7.4 Europe LFA-based Cardiac Marker Market Size by Application (2015-2020)

8 China

  • 8.1 China LFA-based Cardiac Marker Market Size (2015-2020)
  • 8.2 LFA-based Cardiac Marker Key Players in China (2019-2020)
  • 8.3 China LFA-based Cardiac Marker Market Size by Type (2015-2020)
  • 8.4 China LFA-based Cardiac Marker Market Size by Application (2015-2020)

9 Japan

  • 9.1 Japan LFA-based Cardiac Marker Market Size (2015-2020)
  • 9.2 LFA-based Cardiac Marker Key Players in Japan (2019-2020)
  • 9.3 Japan LFA-based Cardiac Marker Market Size by Type (2015-2020)
  • 9.4 Japan LFA-based Cardiac Marker Market Size by Application (2015-2020)

10 Southeast Asia

  • 10.1 Southeast Asia LFA-based Cardiac Marker Market Size (2015-2020)
  • 10.2 LFA-based Cardiac Marker Key Players in Southeast Asia (2019-2020)
  • 10.3 Southeast Asia LFA-based Cardiac Marker Market Size by Type (2015-2020)
  • 10.4 Southeast Asia LFA-based Cardiac Marker Market Size by Application (2015-2020)

11 India

  • 11.1 India LFA-based Cardiac Marker Market Size (2015-2020)
  • 11.2 LFA-based Cardiac Marker Key Players in India (2019-2020)
  • 11.3 India LFA-based Cardiac Marker Market Size by Type (2015-2020)
  • 11.4 India LFA-based Cardiac Marker Market Size by Application (2015-2020)

12 Central & South America

  • 12.1 Central & South America LFA-based Cardiac Marker Market Size (2015-2020)
  • 12.2 LFA-based Cardiac Marker Key Players in Central & South America (2019-2020)
  • 12.3 Central & South America LFA-based Cardiac Marker Market Size by Type (2015-2020)
  • 12.4 Central & South America LFA-based Cardiac Marker Market Size by Application (2015-2020)

13 Key Players Profiles

  • 13.1 Thermo Fisher
    • 13.1.1 Thermo Fisher Company Details
    • 13.1.2 Thermo Fisher Business Overview and Its Total Revenue
    • 13.1.3 Thermo Fisher LFA-based Cardiac Marker Introduction
    • 13.1.4 Thermo Fisher Revenue in LFA-based Cardiac Marker Business (2015-2020))
    • 13.1.5 Thermo Fisher Recent Development
  • 13.2 Bio-Rad Laboratories
    • 13.2.1 Bio-Rad Laboratories Company Details
    • 13.2.2 Bio-Rad Laboratories Business Overview and Its Total Revenue
    • 13.2.3 Bio-Rad Laboratories LFA-based Cardiac Marker Introduction
    • 13.2.4 Bio-Rad Laboratories Revenue in LFA-based Cardiac Marker Business (2015-2020)
    • 13.2.5 Bio-Rad Laboratories Recent Development
  • 13.3 Becton, Dickinson
    • 13.3.1 Becton, Dickinson Company Details
    • 13.3.2 Becton, Dickinson Business Overview and Its Total Revenue
    • 13.3.3 Becton, Dickinson LFA-based Cardiac Marker Introduction
    • 13.3.4 Becton, Dickinson Revenue in LFA-based Cardiac Marker Business (2015-2020)
    • 13.3.5 Becton, Dickinson Recent Development
  • 13.4 Roche
    • 13.4.1 Roche Company Details
    • 13.4.2 Roche Business Overview and Its Total Revenue
    • 13.4.3 Roche LFA-based Cardiac Marker Introduction
    • 13.4.4 Roche Revenue in LFA-based Cardiac Marker Business (2015-2020)
    • 13.4.5 Roche Recent Development
  • 13.5 Hologic
    • 13.5.1 Hologic Company Details
    • 13.5.2 Hologic Business Overview and Its Total Revenue
    • 13.5.3 Hologic LFA-based Cardiac Marker Introduction
    • 13.5.4 Hologic Revenue in LFA-based Cardiac Marker Business (2015-2020)
    • 13.5.5 Hologic Recent Development
  • 13.6 Abbott
    • 13.6.1 Abbott Company Details
    • 13.6.2 Abbott Business Overview and Its Total Revenue
    • 13.6.3 Abbott LFA-based Cardiac Marker Introduction
    • 13.6.4 Abbott Revenue in LFA-based Cardiac Marker Business (2015-2020)
    • 13.6.5 Abbott Recent Development
  • 13.7 Siemens
    • 13.7.1 Siemens Company Details
    • 13.7.2 Siemens Business Overview and Its Total Revenue
    • 13.7.3 Siemens LFA-based Cardiac Marker Introduction
    • 13.7.4 Siemens Revenue in LFA-based Cardiac Marker Business (2015-2020)
    • 13.7.5 Siemens Recent Development
  • 13.8 Danaher
    • 13.8.1 Danaher Company Details
    • 13.8.2 Danaher Business Overview and Its Total Revenue
    • 13.8.3 Danaher LFA-based Cardiac Marker Introduction
    • 13.8.4 Danaher Revenue in LFA-based Cardiac Marker Business (2015-2020)
    • 13.8.5 Danaher Recent Development
  • 13.9 Alere
    • 13.9.1 Alere Company Details
    • 13.9.2 Alere Business Overview and Its Total Revenue
    • 13.9.3 Alere LFA-based Cardiac Marker Introduction
    • 13.9.4 Alere Revenue in LFA-based Cardiac Marker Business (2015-2020)
    • 13.9.5 Alere Recent Development
  • 13.10 BioMérieux
    • 13.10.1 BioMérieux Company Details
    • 13.10.2 BioMérieux Business Overview and Its Total Revenue
    • 13.10.3 BioMérieux LFA-based Cardiac Marker Introduction
    • 13.10.4 BioMérieux Revenue in LFA-based Cardiac Marker Business (2015-2020)
    • 13.10.5 BioMérieux Recent Development
  • 13.11 LSI
    • 10.11.1 LSI Company Details
    • 10.11.2 LSI Business Overview and Its Total Revenue
    • 10.11.3 LSI LFA-based Cardiac Marker Introduction
    • 10.11.4 LSI Revenue in LFA-based Cardiac Marker Business (2015-2020)
    • 10.11.5 LSI Recent Development
  • 13.12 Clinical Diagnostics
    • 10.12.1 Clinical Diagnostics Company Details
    • 10.12.2 Clinical Diagnostics Business Overview and Its Total Revenue
    • 10.12.3 Clinical Diagnostics LFA-based Cardiac Marker Introduction
    • 10.12.4 Clinical Diagnostics Revenue in LFA-based Cardiac Marker Business (2015-2020)
    • 10.12.5 Clinical Diagnostics Recent Development
  • 13.13 Randox laboratories
    • 10.13.1 Randox laboratories Company Details
    • 10.13.2 Randox laboratories Business Overview and Its Total Revenue
    • 10.13.3 Randox laboratories LFA-based Cardiac Marker Introduction
    • 10.13.4 Randox laboratories Revenue in LFA-based Cardiac Marker Business (2015-2020)
    • 10.13.5 Randox laboratories Recent Development
  • 13.14 Wondfo Biotech
    • 10.14.1 Wondfo Biotech Company Details
    • 10.14.2 Wondfo Biotech Business Overview and Its Total Revenue
    • 10.14.3 Wondfo Biotech LFA-based Cardiac Marker Introduction
    • 10.14.4 Wondfo Biotech Revenue in LFA-based Cardiac Marker Business (2015-2020)
    • 10.14.5 Wondfo Biotech Recent Development

14 Analyst's Viewpoints/Conclusions

    15 Appendix

    • 15.1 Research Methodology
      • 15.1.1 Methodology/Research Approach
      • 15.1.2 Data Source
    • 15.2 Disclaimer

    This report focuses on the global LFA-based Cardiac Marker status, future forecast, growth opportunity, key market and key players. The study objectives are to present the LFA-based Cardiac Marker development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.

    The key players covered in this study
    Thermo Fisher
    Bio-Rad Laboratories
    Becton, Dickinson
    Roche
    Hologic
    Abbott
    Siemens
    Danaher
    Alere
    BioMérieux
    LSI
    Clinical Diagnostics
    Randox laboratories
    Wondfo Biotech

    Market segment by Type, the product can be split into
    Troponin
    CK-MB
    Myoglobin
    Others
    Market segment by Application, split into
    Laboratory Testing
    Point-of-care Testing

    Market segment by Regions/Countries, this report covers
    North America
    Europe
    China
    Japan
    Southeast Asia
    India
    Central & South America

    The study objectives of this report are:
    To analyze global LFA-based Cardiac Marker status, future forecast, growth opportunity, key market and key players.
    To present the LFA-based Cardiac Marker development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
    To strategically profile the key players and comprehensively analyze their development plan and strategies.
    To define, describe and forecast the market by type, market and key regions.

    In this study, the years considered to estimate the market size of LFA-based Cardiac Marker are as follows:
    History Year: 2015-2019
    Base Year: 2019
    Estimated Year: 2020
    Forecast Year 2020 to 2026
    For the data information by region, company, type and application, 2019 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

    Buy now